Stage Prognosis depends on the stage of the cancer. For intraepithelial<unk>  neoplasmas the prognosis is good. With treatment, the five-year relative survival rate for the earliest stage of invasive<unk>  is 92%, and the overall (all stages combined) five-year survival rate is about 66%. These statistics may be improved when applied to women newly diagnosed, bearing in mind that these outcomes may be partly based on the state of treatment five years ago when the women studied were first diagnosed. With treatment, 80–90% of women with stage I cancer and 60–75% of those with stage II cancer are alive 5 years after diagnosis. Survival rates decrease to 58% for women with stage III cancer and 17% or fewer of those with stage IV cancer five years after diagnosis. Recurrent<unk>  detected at its earliest stages might be successfully treated with surgery, radiation, chemotherapy, or a combination of the three. About 35% of women with invasive<unk>  have persistent or recurrent disease after treatment. By country Five year survival in the United States for White women is 69% and for Black women is 57%. Regular screening has meant that precancerous changes and early-stage<unk> s have been detected and treated early. Figures suggest that<unk>  screening is saving 5,000 lives each year in the UK by preventing<unk> . About 1,000 women per year die of<unk>  in the UK. All of the Nordic countries have<unk> -screening programs in place. The Pap test was integrated into clinical practice in the Nordic countries in the 1960s. In Africa outcomes are often worse as diagnosis is frequently at a latter stage of disease. In a scoping review of publicly-available<unk>  prevention and control plans from African countries, plans tended to emphasize survivorship rather than early HPV diagnosis and prevention.
Cervical cancer
Vaginal cancer
Endometrial cancer
Uterine cancer
Ovarian cancer
Breast cancer
Ovarian disease
Breast disease